https://endpoints.news/chinas-zhongmou-seeks-to-create-a-one-size-fits-all-rival-to-luxturna/
China’s Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna
Nov 26, 2025 - Wuhan-based Zhongmou Therapeutics reports promising results from gene therapy trial for retinitis pigmentosa, with 7 of 9 blind patients showing vision...
chinazhongmouseekscreatesize
https://www.clinicaltrialsarena.com/news/zhongmou-therapeutics-rp-gene-therapy-shows-promise-in-first-in-human-trial/
Zhongmou Therapeutics’ RP gene therapy shows promise in first-in-human trial - Clinical Trials...
Nov 27, 2025 - Zhongmou’s gene therapy has shown promise in treating the symptoms of retinitis pigmentosa (RP) in a single-site trial in China.
gene therapyshows promiserp